Skip to main content

Advertisement

Log in

Activation of Mononuclear Cells by Interleukin-12: An In Vivo Study in Chimpanzees

  • Published:
Journal of Clinical Immunology Aims and scope Submit manuscript

Abstract

Interleukin (IL)-12 is considered a central regulator of host resistance against a variety of pathogens. Therefore, IL-12 has been advocated as a potential therapeutic agent in infections. To determine the in vivo effects of IL-12 on mononuclear cells involved in the host immune response, four chimpanzees received an intravenous injection of recombinant IL-12 (1 μg/kg). IL-12 induced a sustained decrease in lymphocyte counts, with decreases in CD3+/CD4+ and CD3+/CD8+ cells, while monocyte counts showed a transient increase. IL-12 injection resulted in a shift toward a Th1-mediated immune response as indicated by increased interferon-γ production during whole-blood stimulation, while not influencing IL-4 production. IL-12-induced activation of NK cells and phagocytes, as indicated by increased NK cell cytotoxicity and increased plasma levels of granzymes A and B and of chitotriosidase activity. These data support the hypothesis that IL-12 may serve as a useful therapeutic agent in infections where a cell-mediated response is protective.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008-4027, 1994

    Google Scholar 

  2. Schiff DE, Rae J, Martin TR, Davis BH, Curnutte JT: Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood 90:3187-3194, 1997

    Google Scholar 

  3. Seder RA, Kelsall BL, Jankovic D: Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. J Immunol 157:2745-2748, 1996

    Google Scholar 

  4. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276, 1995

    Google Scholar 

  5. Locksley RM: Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci USA 90:5879-5880, 1993

    Google Scholar 

  6. Romani L, Puccetti P, Bistoni F: Interleukin-12 in infectious diseases. Clin Microbiol Rev 10:611-636, 1997

    Google Scholar 

  7. Cooper AM, Magram J, Ferrante J, Orme IM: Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186:39-45, 1997

    Google Scholar 

  8. Mattner F, Di Padova K, Alber G: Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect Immun 65:4378-83, 1997

    Google Scholar 

  9. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J Immunol 152:1883-1887, 1994

    Google Scholar 

  10. Cooper AM, Roberts AD, Rhoades ER, Callahan JE, Getzy DM, Orme IM: The role of interleukin-12 in aquired immunity to Mycobacterium tuberculosis infection. Immunology 84:423-432, 1995

    Google Scholar 

  11. Flynn JL, Goldstein MM, Triebold KJ, Sypek J, Wolf S, and Bloom BR: IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol 155:2515-2524, 1995

    Google Scholar 

  12. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med 177:1505-1509, 1993

    Google Scholar 

  13. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 177:1797-1802, 1993

    Google Scholar 

  14. Wagner RD, Steinberg H, Brown JF, Czuprynski CJ: Recombinant interleukin-12 enhances resistance of mice to Listeria monocytogenes infection. Microbial Pathogenesis 17:175-186, 1994

    Google Scholar 

  15. Greenberger MJ, Kunkel SL, Strieter RM, Lukaacs NW, Bramson J, Gauldie J, Graham FL, Hitt M, Danforth JM, Standiford TJ: IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. J Immunol 157:3006-3012, 1996

    Google Scholar 

  16. Hoffman SL, Crutcher JM, Puri SK, Ansari AA, Villinger F, Franke ED, Singh PP, Finkelman F, Gately MK, Dutta GP, Sedegah M: Sterile protection of monkeys against malaria after administration of interleukin-12. Nature Med 3:80-83, 1997

    Google Scholar 

  17. Lauw FN, Dekkers PEP, Te Velde AA, Speelman P, Levi M, Kurimoto M, Hack CE, Van Deventer SJH, Van der Poll T: Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 179:646-652, 1999

    Google Scholar 

  18. Spits H, Ijssel H, Terhorst C, de Vries JE: Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: Isolation of clones that differ in phenotype and specificity. J Immunol 128:95-99, 1982

    Google Scholar 

  19. Quaranta V, Walker LE, Pellegrino MA, Ferrone S: Purification of immunologically functional subsets of human Ia-like antigens on a monoclonal antibody (Q5/13) immunoadsorbent. J Immunol 125:1421-1425, 1980

    Google Scholar 

  20. Rabinowich H, Sedlmayr P, Herberman RB, Whiteside TL: Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells. Cell Immunol 135:454-470, 1991

    Google Scholar 

  21. Spaeny-Dekking EA, Hanna WL, Wolbink AM, Wever PC, Kummer AJ, Swaak AJG, Middeldorp JM, Huisman HG, Froelich CJ, Hack CE: Extracellular granzymes A and B in man: Detection of native species during CTL responses in vitro and in vivo. J Immunol 160:3610-3616, 1998

    Google Scholar 

  22. Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JM: Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins. J Biol Chem 270:2198-2202, 1995

    Google Scholar 

  23. Bree AG, Schlerman FJ, Kaviani MD, Hastings RC, Hitz SL, Goldman SJ: Multiple effects on peripheral hematology following administration of recombinant human interleukin 12 to nonhuman primates. Biochem Biophys Res Commun 204:1150-1157, 1994

    Google Scholar 

  24. Kohl S, Sigaroudinia M, Charlebois ED, Jacobson MA: Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells. J Infect Dis 174:1105-1108, 1996

    Google Scholar 

  25. Atkins MB, Robertson MJ, Gordon M, Lotze MT, M. D, Dubois JS, Ritz J, Sandler AB, Edington HD, Garzone PD, Mier JW, Canning CM, Battiato L, Tahara H, Sherman ML: Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin Cancer Res 3:409-417, 1997

    Google Scholar 

  26. Leonard JP, Sherman ML, Fisher GL, Buchanan LJ, Larsen G, Atkins MB, Sosman JA, Dutcher JP, Vogelzang NJ, Ryan JL: Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood 90:2541-8, 1997

    Google Scholar 

  27. Gollob JA, Schnipper CP, Orsini E, Murphy E, Daley JF, Lazo Sb, Frank DA, Neuberg D, Ritz J: Characterization of a novel subset of CD8+ T cells that expands in patients receiving interleukin-12. J Clin Invest 102:561-575, 1998

    Google Scholar 

  28. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Buller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 93:114-120, 1994

    Google Scholar 

  29. van Leenen D, van der Poll T, Levi M, ten Cate H, van Deventer SJ, Hack CE, Aarden LA, ten Cate JW: Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol 151:2318-2325, 1993

    Google Scholar 

  30. Decker D, Schöndorf M, Bidlingmaier F, Hirner A, von Ruecker AA: Surgical stress induces a shift in the type-1/ type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 119:316-325, 1996

    Google Scholar 

  31. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, Wagner H, Siewert JR, Holzmann B: Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65:2283-2291, 1997

    Google Scholar 

  32. Mossman TR, Sad S: The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146, 1996

    Google Scholar 

  33. Mureille E, Leo O: Revisiting the Th1/Th2 paradigm. Scand J Immunol 47:1-9, 1998

    Google Scholar 

  34. Abbas AK, Murphy KM, Sher A: Functional diversity of helper T lymphocytes. Nature 383:787-793, 1996

    Google Scholar 

  35. Petrovsky N, and Harrison LC: Diurnal rhythmicity of human cytokine production. A dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol 158:5163-5168, 1997

    Google Scholar 

  36. De Groote D, Zangerle PF, Gevaert Y, Fassotte MF, Beguin Y, Noizat-Pirenne F, Pirenne J, Gathy R, Lopez M, Dehart I, et al.: Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 4:239-248, 1992

    Google Scholar 

  37. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 5:503-510, 1993

    Google Scholar 

  38. Berke G: Unlocking the secrets of CTL and NK cells. Immunol Today 16:343-346, 1995

    Google Scholar 

  39. Smyth MJ, Trapani. aJA: Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202-206, 1995

    Google Scholar 

  40. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET: IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell Immunol 165:33-43, 1995

    Google Scholar 

  41. Salcedo TW, Azzoni L, Wolf SF, Perussia B: Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 151:2511-2520, 1993

    Google Scholar 

  42. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725-3729, 1993

    Google Scholar 

  43. Carson WE, Ross ME, Baiocchi RA, Marlen MJ, Boiani N, Grabstein K, Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-g by natural killer cells in vitro. J Clin Invest 96:2578-2582, 1995

    Google Scholar 

  44. Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A: Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 65:3594-3599, 1997

    Google Scholar 

  45. Kubin M, Kamoun M, Trinchieri G: Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med 180:211-222, 1994

    Google Scholar 

  46. Gollob JA, Li J, Kawasaki H, Daley JF, Groves C, Reinherz EL, Ritz J: Molecular interaction between CD58 and CD2 counter-receptors mediates the ability of monocytes to augment T cell activation by IL-12. J Immunol 157:1886-1893, 1996

    Google Scholar 

  47. Gollob JA, Ritz J: CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness. Adhesion molecules link innate and acquired immunity. Ann NY Acad Sci 795:71-81, 1996

    Google Scholar 

  48. Hollak CE, van Weely S, van Oers MH, Aerts JM: Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93:1288-1292, 1994

    Google Scholar 

  49. Guo Y, He W, Boer AM, Wevers RA, de Bruijn AM, Groener JE, Hollak CE, Aerts JM, Galjaard H, van Diggelen OP: Elevated plasma chitotriosidase activity in various lysosomal storage disorders. J Inher Metab Dis 18:717-722, 1995

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lauw, F.N., Te Velde, A.A., Dekkers, P.E.P. et al. Activation of Mononuclear Cells by Interleukin-12: An In Vivo Study in Chimpanzees. J Clin Immunol 19, 231–238 (1999). https://doi.org/10.1023/A:1020520130792

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020520130792

Navigation